🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss — looking for input Page 3

Semaglutide cardiovascular benefit independent of weight loss — looking for input

Dr.PeteFamMed Mon, Apr 27, 2026 at 1:38 AM 21 replies 664 viewsPage 3 of 5
A1cHero_PHX
Member
523
2,678
Jul 2024
Phoenix, AZ
Apr 28, 2026 at 12:16 AM#11
roxy_nash said:
The dose-response is real but shallow at the top.

Bookmarking. The distinction being drawn above is the one nobody else makes. Taking it to my next appointment.

Last edited: Apr 28, 2026 at 5:16 AM
34 9zoe_NC, Dr.ObesityLA, NurseKim_ATL and 31 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Apr 28, 2026 at 3:14 AM#12

From the other side of the consultation, briefly.

Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my key markers:

Weight: consistent downtrend, -2.1 lbs/week average
Fasting glucose (finger stick): stable at 82 mg/dL
Blood pressure (home): 116/72 average
Resting heart rate: 62 bpm (down from 78)
Waist circumference: down 12 inches total

The resting heart rate improvement correlates with cardiovascular fitness gains. Everything is moving in the right direction.

Last edited: Apr 28, 2026 at 5:14 AM
33 8Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 30 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Apr 28, 2026 at 6:12 AM#13
Dr.BariatricHTX said:
The mechanism that matters here is not stomach emptying, it is central.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

32 7SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Apr 28, 2026 at 9:10 AM#14
Dr.PeteFamMed said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 7.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 2.5 mg/L (moderate risk)
Month 12 hsCRP: 0.4 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 14% to 5%. My cardiologist is genuinely impressed.

31 6PharmHunterJen, TomTeleRx, DoseLogDan and 28 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 28, 2026 at 12:08 PM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Report rather than reply if it drifts again.

30 5PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register